Log in to save to my catalogue

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_941bfc794b394932b6337bc833d81735

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

About this item

Full title

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

Publisher

London, England: SAGE Publications

Journal title

Therapeutic Advances in Musculoskeletal Disease, 2022, Vol.14, p.1759720X211073001-1759720X211073001

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

The antimalarial hydroxychloroquine (HCQ) has demonstrated several crucial properties for the treatment of systemic lupus erythematosus (SLE). Herein, we reviewed the main HCQ pharmacologic features, detailed its mechanism of action, and summarized the existing guidelines and recommendations for HCQ use in rheumatology with a systematic literature...

Alternative Titles

Full title

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_941bfc794b394932b6337bc833d81735

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_941bfc794b394932b6337bc833d81735

Other Identifiers

ISSN

1759-720X

E-ISSN

1759-7218

DOI

10.1177/1759720X211073001

How to access this item